Results 181 to 190 of about 85,740 (261)

Evaluation of Patients under Investigation for MERS-CoV Infection, United States, January 2013–October 2014 [PDF]

open access: diamond, 2015
Eileen Schneider   +5 more
openalex   +1 more source

Two-year persistence of MERS-CoV-specific antibody and T cell responses after MVA-MERS-S vaccination in healthy adults. [PDF]

open access: yesNat Commun
Mayer L   +17 more
europepmc   +1 more source

Intranasal CD40-targeted recombinant MERS-CoV S1 protein is superior to intramuscular immunization in eliciting systemic and mucosal immune responses in mice

open access: hybrid
Muhammad Yasir Khan   +26 more
openalex   +1 more source

Designed miniproteins potently inhibit and protect against MERS-CoV. [PDF]

open access: yesCell Rep
Ragotte RJ   +22 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy